Lora Marden

Lora Marden has a diverse work experience spanning over several companies and roles. Lora is currently a member of the Chief organization, starting in 2022. Prior to that, they served as the Vice President of Patient Advocacy, Engagement & Innovation at Cogent Biosciences, starting in 2022. In 2021, Lora served as a Board Member at the MassBioEd Foundation, where they contributed to talent development in the Massachusetts life sciences workforce. From 2020 to 2022, they worked as the Executive Director and Head of Global Patient Advocacy & Engagement at Kiniksa Pharmaceuticals. Before that, they held roles as the Senior Director of Rare Disease Marketing at Sobi - North America from 2018 to 2020, and Interim Head/Director of Global Patient Advocacy & Engagement at Alnylam Pharmaceuticals from 2016 to 2018. Lora has also worked at Sanofi Genzyme in various positions, including Director of Fabry and Rare Disease Portfolio Marketing & Operations, Senior Manager/Acting Director of Rare Disease Portfolio Marketing & Operations, and other marketing and patient services roles from 2006 to 2016. Their early career started as a Social Worker at the Commonwealth of Massachusetts from 2004 to 2006.

Lora Marden began their education at the University of Rochester in 1999, where they pursued a Bachelor's degree in Psychology. Lora studied in this program for four years, graduating in 2003. Later, in 2012, Lora attended The University of Chicago Booth School of Business for an Executive Education Program in Strategic Marketing Management. No specific field of study was provided for this program.